Angiographic Catheters Market Report 2025

This Angiographic Catheters market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The angiographic catheters market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.42 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing incidences of cardiovascular diseases, a rise in domestic income, a rising geriatric population, increasing preferences for minimally invasive surgeries, and government initiatives to raise awareness.

The angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for accurate diagnosis, a rise in healthcare expenditure, an expansion in e-commerce for medical supplies, an increasing prevalence of chronic diseases, and the adoption of minimally invasive procedures. Major trends in the forecast period include technological advancements, growth in R&D activities, integration of AI in diagnostics, growth of telemedicine, rise in personalized medicine, and expansion of outpatient care.

The increasing frequency of heart surgeries is expected to drive the growth of the angiographic catheters market in the future. Heart surgery, also referred to as cardiac surgery, includes a range of procedures performed on the heart or major vessels. This rise in heart surgeries is attributed to factors such as an aging population, growing prevalence of cardiovascular diseases, advancements in medical technology, and improved surgical outcomes. Angiographic catheters are essential in these surgeries, as they allow for the visualization of coronary arteries, enabling accurate diagnosis and treatment of blockages or abnormalities. For example, the National Health Service (NHS) reported that in August 2023, there were 215 heart transplant surgeries performed in the UK during the 2021-2022 financial year, marking a 20% increase from the 179 surgeries conducted in the previous year (2020-2021). This increase in heart surgeries is contributing to the expansion of the angiographic catheters market.

Leading companies in the angiographic catheters market are increasingly focusing on developing advanced technologies, such as Fiber Optic RealShape (FORS) technology, to provide real-time, high-resolution 3D imaging during catheter navigation. This technology minimizes radiation exposure and enhances precision in complex vascular procedures. FORS is an advanced imaging platform that uses light reflected through optical fibers within medical devices to produce real-time, high-definition 3D visuals of their shape inside the body, facilitating precise navigation in minimally invasive surgeries. For example, in February 2024, Philips Healthcare, a Netherlands-based health technology company, introduced LumiGuide, a light-based, radiation-free catheter guidance system for endovascular aortic procedures. LumiGuide leverages FORS technology to generate real-time 3D images of devices within the body, allowing for navigation without the need for X-ray angiography. Key features include enhanced 3D visualization, reduced radiation exposure, immediate feedback on device orientation, and AI-assisted registration for greater accuracy in complex procedures. Available in select hospitals across Europe and the U.S., LumiGuide aims to improve both patient safety and procedural efficiency.

In October 2023, Cordis Medical Device Co., Ltd., a US-based medical company, acquired MedAlliance Swiss Medical Technology for an undisclosed sum. This acquisition is set to enhance Cordis's capacity to advance access to innovative technology, thereby improving patient care in the cardiovascular field. The acquisition aims to expand Cordis’s portfolio by incorporating advanced solutions for treating vascular diseases. MedAlliance Swiss Medical Technology, based in Switzerland, specializes in the development of angiographic catheters.

Major companies operating in the angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc.

North America was the largest region in the angiographic catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angiographic catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the angiographic catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Angiographic catheters are specialized medical tools used during angiography to both diagnose and treat issues within the blood vessels. These slender, flexible tubes are inserted into the vascular system to deliver contrast dye, which allows for real-time X-ray imaging (angiograms) of arteries, veins, and heart chambers. This imaging helps doctors evaluate blockages, aneurysms, and other vascular conditions.

The main types of angiographic catheters include conventional catheters, drug-eluting balloon catheters, cutting balloon catheters, and scoring balloon catheters. Conventional catheters, also known as non-coated catheters, represent the traditional design for intermittent urinary use. The technologies involved are X-ray, magnetic resonance angiography (MRA), and computed tomography (CT). These catheters are utilized in various fields such as coronary, endovascular, neurology, oncology, and others. They are employed by a range of end users, including hospitals, ambulatory surgical centers, cardiac centers, brain centers, specialty clinics, and more.

The angiographic catheters market research report is one of a series of new reports that provides angiographic catheters market statistics, including angiographic catheters industry global market size, regional shares, competitors with a angiographic catheters market share, detailed angiographic catheters market segments, market trends and opportunities, and any further data you may need to thrive in the angiographic catheters industry. This angiographic catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The angiographic catheters market consists of sales of catheter shafts, tips, lumens, connectors, and balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.